HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization.

Abstract
Hereditary familial amyloidosis of Finnish type (FAF) leading to amyloid in the peripheral and central nervous systems stems from deposition of a 71 residue fragment generated from the D187N/Y variants of plasma gelsolin by two sequential endoproteolytic events. We identify the protease accomplishing the first cleavage as furin, a proprotein convertase. Endoproteolysis of plasma gelsolin occurs in the trans-Golgi network due to the inability of the FAF variants to bind and be stabilized by Ca(2+). Secretion and processing of the FAF variants by furin can be uncoupled by blocking the convergence of the exocytic pathway transporting plasma gelsolin and the endocytic recycling of furin. We propose that coincidence of membrane trafficking pathways contributes to the development of proteolysis-initiated amyloid disease.
AuthorsC D Chen, M E Huff, J Matteson, L Page, R Phillips, J W Kelly, W E Balch
JournalThe EMBO journal (EMBO J) Vol. 20 Issue 22 Pg. 6277-87 (Nov 15 2001) ISSN: 0261-4189 [Print] England
PMID11707399 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Gelsolin
  • Subtilisins
  • Furin
  • Calcium
Topics
  • Amyloidosis, Familial (metabolism)
  • Animals
  • Calcium (metabolism)
  • Calorimetry
  • Cell Line
  • Cell Membrane (metabolism)
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Endocytosis
  • Furin
  • Gelsolin (blood, metabolism)
  • Genetic Variation
  • Golgi Apparatus (metabolism)
  • Protein Binding
  • Protein Structure, Tertiary
  • Subtilisins (chemistry, metabolism)
  • Thermodynamics
  • Time Factors
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: